Lehrstuhl für Geburtshilfe und Frauenheilkunde

Can Sonographic Fetal Biometry Predict Adverse Perinatal Outcome? (2019) Pretscher J, Schwenke E, Baier F, Kehl S, Schneider M, Stumpfe FM, Schmid M, et al. Journal article Analysis of GDF15 and IGFBP7 in Hyperemesis Gravidarum Support Causality (2019) Fejzo MS, Fasching P, Schneider M, Schwitulla J, Beckmann M, Schwenke E, Macgibbon KW, Mullin PM Journal article Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients (2019) Nabieva N, Häberle L, Brucker SY, Janni W, Volz B, Löhberg C, Hartkopf AD, et al. Journal article Diagnostic Accuracy of Breast Medical Tactile Examiners (MTEs): A Prospective Pilot Study (2019) Lux MP, Emons J, Bani M, Wunderle M, Sell C, Preuss C, Rauh C, et al. Journal article Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis (2019) Fasching P, Hartkopf AD, Gaß P, Häberle L, Akpolat-Basci L, Hein A, Volz B, et al. Journal article Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (2019) Mavaddat N, Michailidou K, Dennis J, Lush M, Fachal L, Lee A, Tyrer JP, et al. Journal article Resilience, Fear of Progression and Psychosocial Distress in Patients with Breast Cancer and Gynecological Tumors Seeking a Second Opinion. (2018) Krebs J, Wasner S, Egloffstein S, Lux MP, Morawa E, Beckmann M, Erim Y Journal article Impact of nab-paclitaxel dose reduction on survival of the randomized phase III GeparSepto trial comparing neoadjuvant chemotherapy of weekly nab-paclitaxel (nP) with solvent-based paclitaxel (P) followed by anthracycline/cyclophosphamide for patients with early breast cancer (BC) (2018) Untch M, Jackisch C, Schneeweiss A, Schmatloch S, Aktas B, Denkert C, Schem C, et al. Conference contribution Evaluation of the MammaTyperVR as a molecular predictor for pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) and outcome in patients with different breast cancer (BC) subtypes (2018) Fasching P, Laible M, Weber KE, Wirtz RM, Denkert C, Schlombs K, Schmatloch S, et al. Conference contribution Validation of the MammaTyper (R) pathological complete response (pCR)-score as a predictor for response after neoadjuvant chemotherapy (NACT) in patients with early breast cancer (BC) (2018) Fasching P, Laible M, Weber KE, Wirtz RM, Denkert C, Schlombs K, Schmatloch S, et al. Conference contribution